GLP-1 Market
LLY $1123.00 ▼ -0.1% NVO $44.01 ▼ -1.2% PFE $27.65 ▼ -0.5% VKTX $32.13 ▼ -1.7% KLRA $14.91 ▲ +0.5% GPCR $39.55 ▼ -4.1% RHHBY $53.19 ▼ -0.4% HIMS $27.44 ▼ -1.6% WW $14.78 ▼ -1.1%
Delayed · As of 9:20 AM

Empowering you to have better conversations with your doctor.

Subscribe
About this data Sourced primarily from ClinicalTrials.gov — a listing isn't proof of safety or FDA approval.

Pipeline and clinical trial information here comes primarily from ClinicalTrials.gov. A listing on ClinicalTrials.gov means a study has been registered — not that a treatment is proven safe, effective, or FDA-approved. Investigational treatments may never be approved. Who can join a trial is decided only by that trial's own study team.

Not yet reported

PF-08653944

Company
Pfizer
Mechanism
Mechanism not yet reported
Route
Route not yet reported
Recruiting trials
3 recruiting

Efficacy results: Not yet reported

Find a Clinical Trial Near Me

3 recruiting studies currently listed on ClinicalTrials.gov.

Data source: ClinicalTrials.gov · trial data as of Sep 11, 2026

Find a Clinical Trial Near Me

See recruiting studies for PF-08653944 and check eligibility with the study team.

Select conditions
Match
Treatment type

"Added to GLP-1" means the investigational treatment is being studied on top of an existing GLP-1-based therapy.

Your ZIP code is only used to calculate distance to trial sites — it isn't stored.

Trial details
  • Recruiting NCT NCT07519135

    A Study to Learn About the Medicine Called PF-08653944 in People With and Without Reduced Liver Function

    Not yet reported Pfizer 26 participants Est. completion 2027-07-09 3 sites Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Recruiting NCT NCT07575932

    A Study of PF-08653945 and PF-08653944 in Adults With Overweight or Obesity (SOLIS-1)

    Not yet reported Pfizer 872 participants Est. completion 2028-01-05 65 sites Stand-alone
    Other conditions: Overweight, Obesity, Overweight and/or Obesity, Overweight or Obesity, Overnutrition, Nutrition Disorders, Nutritional and Metabolic Diseases, Body Weight
    View official trial listing →
  • Recruiting NCT NCT07595549

    A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity

    Not yet reported Pfizer 954 participants Est. completion 2028-06-21 50 sites Stand-alone
    Other conditions: Obesity, Overweight and/or Obesity, Overweight
    View official trial listing →
  • Active, not recruiting NCT NCT07311850

    Efficacy and Safety of MET097 Once-Weekly in People With Overweight or Obesity

    Not yet reported Pfizer 3578 participants Est. completion 2028-04-25 169 sites
    Other conditions: Obesity and Overweight
    View official trial listing →
  • Active, not recruiting NCT NCT07400653

    A Study to Learn About the Study Medicine (PF-08653944) in People With Obesity or Overweight and Type 2 Diabetes (T2D)

    Not yet reported Pfizer 1078 participants Est. completion 2028-05-16 188 sites Stand-alone
    Type 2 diabetes Other conditions: Obesity, Overweight and/or Obesity, Overweight, Diabetes, Type 2
    View official trial listing →
  • Completed NCT NCT07400679

    A Study to Learn How the Study Medicine Called PF-08653944 is Taken up Into the Blood in Adults With Overweight or Obesity

    Not yet reported Pfizer 48 participants Est. completion 2026-07-08 1 site Stand-alone
    Other conditions: Overweight, Obesity, Healthy
    View official trial listing →
  • Active, not recruiting NCT NCT07508241

    A Study to Learn About the Effect of Study Medicine Called PF-08653944 on How Quickly the Stomach Empties Its Content in Healthy Adults With Overweight or Obesity

    Not yet reported Pfizer 22 participants Est. completion 2027-01-27 1 site Stand-alone
    Other conditions: Obesity, Overweight and/or Obesity, Overweight, Drug Interaction
    View official trial listing →
  • Not yet recruiting NCT NCT07792954

    A Study to Learn About the Study Medicine Called PF-08653944 Taken Once-Weekly Compared to Placebo in Chinese Adults With Overweight or Obesity

    Not yet reported Pfizer 300 participants Est. completion 2028-05-23 33 sites
    Other conditions: Obesity, Overweight
    View official trial listing →
  • Not yet recruiting NCT NCT07794761

    A Study to Learn About Safety and Effects of Once-weekly Treatment With Berobenatide in Adults With Obesity Disease in Japan (VESPER-JW)

    Not yet reported Pfizer 180 participants Est. completion 2029-03-14 12 sites
    Other conditions: Obesity
    View official trial listing →
  • Not yet recruiting NCT NCT07794774

    A Study to Learn About Safety and Effects of Once-monthly Treatment With Berobenatide in Adults With Obesity Disease in Japan (VESPER-JM)

    Not yet reported Pfizer 197 participants Est. completion 2029-02-21 11 sites
    Other conditions: Obesity
    View official trial listing →
Efficacy history

Not yet reported.

Safety

Not yet reported.

Sources
Related On The Pen coverage

No related coverage yet.

This drug may be investigational and not yet approved for any use. Whether someone can join a clinical trial is determined only by that trial's own study team — On The Pen does not determine eligibility. Information here can change; always confirm current details on the official ClinicalTrials.gov listing or with the sponsor.